TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/3/21 17:15 | 2/1/21 | SYNH | Syneos Health, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Colvin Paul | NC | O | P,Clinic | S | -635 | 74.82 | 0 | -8 | -23 | 28 | D | ||||||||||||||
3/23/20 17:06 | 3/19/20 | SYNH | Syneos Health, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Colvin Paul | NC | O | P,Clinic | P | 48 | 36.65 | 0 | 1 | 5 | 27 | D | ||||||||||||||
5/27/11 14:07 | 5/26/11 | PPDI | Pharmaceutical Product Development Inc | NC | Health | Biolab | Commercial Physical & Biologi | Colvin Paul | NC | O | EVP--Cli | M.dm | 118 | 20.41 | 0 | 6 | 0 | D | |||||||||||||||
5/27/11 14:07 | 5/26/11 | PPDI | Pharmaceutical Product Development Inc | NC | Health | Biolab | Commercial Physical & Biologi | Colvin Paul | NC | O | EVP--Cli | S.dm | -165 | 28.70 | 0 | -6 | -100 | 0 | D | ||||||||||||||
5/23/11 15:36 | 5/20/11 | PPDI | Pharmaceutical Product Development Inc | NC | Health | Biolab | Commercial Physical & Biologi | Colvin Paul | NC | O | EVP--Cli | M.d | 12 | 20.10 | 0 | 1 | 0 | D | |||||||||||||||
5/23/11 15:36 | 5/20/11 | PPDI | Pharmaceutical Product Development Inc | NC | Health | Biolab | Commercial Physical & Biologi | Colvin Paul | NC | O | EVP--Cli | S.d | -17 | 29.01 | 0 | -1 | -100 | 0 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |